Literature DB >> 24684170

An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.

Sreejesh Sreedharanunni1, Kusum Joshi, Rajan Duggal, Ritambhra Nada, Mukut Minz, Vinay Sakhuja.   

Abstract

Glomerular diseases of the transplanted kidney are the most important cause of poor long- term outcome. The estimation of the magnitude of this problem and an elucidation of pathogenic mechanism is essential for improvement of graft survival. This study from the Indian subcontinent aims (i) to determine the incidence of transplant glomerulopathy (TG) and thrombotic microangiopathy (TMA) in a large cohort of indicated renal transplant biopsies, (ii) to evaluate the histological and ultrastructural features of TG and TMA, and (iii) to assess the relationship between the two glomerular lesions. Of a total of 1792 indication renal transplant biopsies received over 5 years (2006-2010), 266 biopsies (of 249 patients) had significant glomerular pathology and were further analyzed along with immunofluorescence, electron microscopy (EM), and C4d immunohistochemistry. TG is the most common glomerular lesion followed by TMA seen in 5.97% and 5.08% of allograft biopsies, respectively, which constitutes 40.23% and 34.2% of biopsies with significant glomerular lesions. Pathologic antibody-mediated rejection (AMR) is associated with both TG and TMA in 71% and 46.5%, respectively. A coexistent TG was found in 18.4% of biopsies with TMA. Endothelial swelling with subendothelial widening, a feature of TMA, is also seen in early TG by EM. Our findings support the concept that TG evolves from a smoldering TMA of various causes.
© 2014 Steunstichting ESOT.

Entities:  

Keywords:  Antibody-mediated rejection; C4d; renal allograft biopsies; thrombotic microangiopathy; transplant glomerulopathy

Mesh:

Substances:

Year:  2014        PMID: 24684170     DOI: 10.1111/tri.12331

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.

Authors:  M Manook; J Kwun; C Burghuber; K Samy; M Mulvihill; J Yoon; H Xu; A L MacDonald; K Freischlag; V Curfman; E Branum; D Howell; A B Farris; R A Smith; S Sacks; A Dorling; N Mamode; S J Knechtle
Journal:  Am J Transplant       Date:  2017-03-23       Impact factor: 8.086

2.  Vascular Occlusion in Kidney Biopsy Is Characteristic of Clinically Manifesting Thrombotic Microangiopathy.

Authors:  Marja Kovala; Minna Seppälä; Kati Kaartinen; Seppo Meri; Eero Honkanen; Anne Räisänen-Sokolowski
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

Review 3.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

4.  Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes.

Authors:  Cínthia Montenegro Teixeira; Hélio Tedesco Silva Junior; Luiz Antônio Ribeiro de Moura; Henrique Machado de Sousa Proença; Renato de Marco; Maria Gerbase de Lima; Marina Pontello Cristelli; Laila Almeida Viana; Cláudia Rosso Felipe; José Osmar Medina Pestana
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

5.  Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation.

Authors:  Andreja Aleš Rigler; Željka Večerić-Haler; Miha Arnol; Martina Perše; Emanuela Boštjančič; Jerica Pleško; Saša Simčič; Nika Kojc
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

Review 6.  Paraffin Immunofluorescence: A Valuable Ancillary Technique in Renal Pathology.

Authors:  Samih H Nasr; Mary E Fidler; Samar M Said
Journal:  Kidney Int Rep       Date:  2018-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.